Products from the acquisition will align with Novus’s MINTREX® chelated trace mineral products and further expand its mineral technology. When complete, this acquisition will enable Novus to offer its customers and the animal agriculture market an expanded chelated trace mineral product portfolio to support their livestock operations.
Geographically, Albion is primarily present in the animal organic trace mineral industry in the US, Europe, the Middle East and Japan. Since its establishment in 1956, Albion has been an innovator in mineral chelate nutrition. Albion manufactures highly bioavailable nutritional mineral forms and has a long-standing customer base in both the beef and dairy markets.
“The intent to acquire Albion’s animal division is consistent with the direction Novus has taken to work with industry partners to achieve greater production efficiencies and minimise environmental impact,” said Giovanni Gasperoni, Executive Vice President, Novus International.
The terms of the proposed deal have not been disclosed.
Related links:
.jpg)
